SRT3

SARTORIUS AG VZO O.N.

Stock XETRA – Stock Market Prices, News & Analysis

Sartorius AG is a German company specializing in for biotechnology and the pharmaceutical industry, including laboratory equipment and production solutions.

€ 212.40
0.24 %

SARTORIUS AG VZO O.N.

212.40
0.24 %
SRT3

Sartorius AG is a German company specializing in for biotechnology and the pharmaceutical industry, including laboratory equipment and production solutions.

Price history of SARTORIUS AG VZO O.N.
Price history of SARTORIUS AG VZO O.N.

Performance & Momentum

6 Months 7.49 %
1 Year 6.09 %
3 Years 48.32 %
5 Years 50.89 %

Strategic Analysis

SARTORIUS AG VZO O.N. • 2026

Sartorius AG positions itself as an essential provider of specialized and equipment for biotechnology and the pharmaceutical industry. Its business model is based on integrated solutions that support pharmaceutical R&D and production, delivering significant technical added value in a growing niche sector.

Strengths
  • Established expertise in laboratory equipment and biopharmaceutical production solutions
  • Strong presence in Germany, a key market for European biotechnology
  • Technological positioning adapted to the growing needs of pharmaceutical research and development
Weaknesses
  • Long-term stock performance degraded despite a buoyant sector
  • Sensitivity to investment cycles in biotechnology and pharmaceuticals
Momentum

Despite a recent positive dynamic represented by a partial recovery after challenging years, the momentum remains volatile. This trend suggests a phase of stabilization with potential opportunities for patient investors, in a favorable but competitive sector context.

Analysis performed 3 weeks ago

Similar stocks to SARTORIUS AG VZO O.N.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone